Treatment of Enterococcus faecalis Urinary Tract Infection
For uncomplicated UTI caused by Enterococcus faecalis, use fosfomycin 3g single dose, nitrofurantoin 100mg four times daily for 5 days, or high-dose ampicillin/amoxicillin (18-30g IV daily divided or 500mg PO/IV every 8 hours). 1
Treatment Algorithm Based on Clinical Scenario
Uncomplicated Cystitis (Lower UTI)
First-line oral options:
- Fosfomycin trometamol 3g single dose - FDA-approved specifically for E. faecalis UTI 1, 2
- Nitrofurantoin 100mg PO every 6 hours for 5 days - excellent activity against E. faecalis with 69.69% sensitivity 1, 3
- High-dose ampicillin (18-30g IV daily in divided doses) or amoxicillin 500mg PO/IV every 8 hours - remains the drug of choice for enterococcal infections when susceptible 1
The 2022 guidelines emphasize that ampicillin is the drug of choice for enterococcal infections, even when ampicillin resistance is reported in vitro for urinary tract infections, because high urinary concentrations can overcome elevated MICs. One retrospective study showed 88.1% clinical cure and 86% microbiological eradication in ampicillin-resistant VRE UTIs treated with ampicillin 1.
Complicated UTI or Pyelonephritis
For febrile UTI or complicated infections:
- Amoxicillin 80-100mg/kg/day (typically 1-2g IV every 4-6 hours) for 14 days is the preferred treatment according to recent French national survey data 4
- Duration: 14 days for most cases, extend to 21 days if severe or slow response 4
Critical point: E. faecalis typically remains highly susceptible to aminopenicillins, with very low resistance rates 5, 6. A 2022 Polish study showed E. faecalis maintained excellent susceptibility to ampicillin and imipenem 5.
Bacteremia or Serious Infections
For E. faecalis bacteremia:
- Linezolid 600mg IV or PO every 12 hours (Strong recommendation) 1
- High-dose daptomycin 8-12mg/kg IV daily, preferably combined with β-lactams (ampicillin, cephalosporins, or carbapenems) for synergy 1
The evidence shows that daptomycin-β-lactam combinations significantly reduce mortality by 77% in VRE with daptomycin MIC ≤2mg/L compared to monotherapy 1. High-dose daptomycin (≥9mg/kg) combined with β-lactams showed superior outcomes (adjusted HR 19.01, p=0.002) 1.
Important caveat: For persistent bacteremia despite appropriate therapy, consider combination daptomycin 10mg/kg IV daily plus linezolid 600mg PO every 12 hours, which has shown efficacy in case reports 7.
Key Clinical Distinctions
E. faecalis vs E. faecium
This distinction is critical for treatment selection:
- E. faecalis (typically 70-95% of enterococcal UTIs): Remains highly susceptible to ampicillin/amoxicillin, with resistance rates <25% 3, 5, 6
- E. faecium: Shows 99.3% resistance to β-lactams and fluoroquinolones, with 48-55% vancomycin resistance 1, 5
Penicillin Allergy Alternative
If true penicillin allergy:
- Linezolid 600mg PO every 12 hours for 14 days (preferred by 51% of French infectiologists) 4
- Fluoroquinolones (levofloxacin/ciprofloxacin) - though 37% consider inappropriate due to resistance concerns 4
- Note: E. faecalis shows 51.4% norfloxacin resistance in recent surveillance 5
Common Pitfalls to Avoid
Don't use tigecycline for bacteremia - it achieves low serum levels due to large volume of distribution, despite being excellent for intra-abdominal infections 1
Don't assume urinalysis negativity rules out infection - obstructive pyelonephritis can present with normal urinalysis but positive blood cultures 8
Don't use cephalosporins or fluoroquinolones empirically - enterococci have intrinsic resistance to cephalosporins, and fluoroquinolone resistance exceeds 50% 5, 6
Differentiate colonization from infection - particularly important in catheterized patients; consider therapeutic abstention if catheterized (51% of physicians), polymicrobial culture (50%), or leukocyturia <10⁴/mL (64%) 4
Consider endocarditis with persistent bacteremia - especially post-urological procedures like TURP; maintain high suspicion if fever persists >3 days despite source control 8, 9
Duration Considerations
- Uncomplicated cystitis: 1-5 days depending on agent 2
- Complicated UTI/pyelonephritis: 14 days (extend to 21 days if severe) 4
- Bacteremia: Minimum 14 days, longer if endocarditis suspected 1
The evidence strongly supports species identification and susceptibility testing to guide definitive therapy, as E. faecalis and E. faecium have dramatically different resistance profiles that directly impact mortality and treatment success 5, 6, 10.